Droxia Trademark Details

Droxia was registered on Tuesday, February 2, 1999 and is currently owned by Bristol-Myers Squibb Company under the registration number 2222043 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 14 years ago on Thursday, January 29, 2009, according to the United State Patent & Trademark Office
Word Mark Droxia
Status Alive Registered 800 — Registered and Renewed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 75318230
Registration Number 2222043
Status Date Thursday, January 29, 2009
Filing Date Thursday, January 29, 2009
Registration Date Tuesday, February 2, 1999
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Goods & Services Pharmaceutical Preparation for the Treatment of Sickle Cell Anemia

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, July 28, 1997
First Use Anywhere Monday, June 1, 1998
First Use In Commerce Monday, June 1, 1998
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.